accūrō Solutions acquires Splashlight Solutions

accūrō Solutions which manages medical bill review and payment processes for payers in the property and casualty industry, has acquired Splashlight Solutions, a national workers’ compensation bill review service provider based in West Des Moines, Iowa. The purchase price was not disclosed.

“The acquisition brings us additional proven resources to support our growth, improve efficiencies and continue to generate positive outcomes for our clients,” accūrō Solutions CEO Kenneth Hannigan, DBA said. “We built an amazing technology platform that automates many functions, yet its potential is only maximized when used by experienced professionals who have such a deep understanding of the P&C industry.”

All Splashlight employees have joined accūrō Solutions, with its CEO and Founder Lisa Gran now serving as Chief Revenue Officer. In addition, Mike Knutter, who led Splashlight’s operations, has become Assistant Vice President of Bill Review.

The deal came about when Gran was investigating technology options to enhance Splashlight’s bill review services. “We wanted something fresh, new, and flexible and were very impressed by accūrō Solutions’ ARC platform,” she said. As conversations continued, Gran and Dr. Hannigan realized it made sense to combine the two companies.

“The acquisition reflects our investors’ commitment to the long-term growth and development of accūrō Solutions as the premiere service provider in the medical bill review industry,” said Chris Feeney, Executive Board Member of accūrō Solutions.

Hot this week

Recor Medical Supports European Society of Cardiology’s Hypertension Guidelines

Record Medical notes the new guidelines, "2024 ESC Guidelines for the management of elevated blood pressure and hypertension," have been published online and recommend the consideration of renal denervation (RDN) as a safe and effective treatment option for patients who have uncontrolled resistant hypertension or those that have uncontrolled hypertension with a higher risk of cardiovascular disease, who express a preference to undergo RDN.

ConTIPI Medical Selects EVERSANA to Support U.S. Commercialization of Non-Surgical Medical Device ProVate for Women with Pelvic Organ Prolapse

EVERSANA is a leading provider of global commercial services to the life sciences industry, to support commercialization for the ProVate device in the United States to help women experiencing pelvic organ prolapse.

Boston Scientific Obtains CE Mark for ACURATE Prime Aortic Valve System

The ACURATE Prime aortic valve system is designed with several features to build upon the clinical performance of the ACURATE neo2™ platform including an additional valve size, which expands the treatment range to patients with a larger anatomy.

Noctrix Health Announces New CMS Reimbursement Codes and Payment for Nidra Tonic Motor Activation Therapy for Restless Legs Syndrome

Nidra TOMAC Tonic Motor Activation Therapy, which was authorized for marketing in the United States last year following its designation as a "Breakthrough Device" by the US Food & Drug Administration (FDA), remains the only clinically validated, non-pharmaceutical treatment available for patients with RLS.

Haemonetics Announces Full Market Release for VASCADE MVP® XL Vascular Closure System

Haemonetics notes the VASCADE MVP XL system is now available to U.S. hospitals as the newest addition to Haemonetics' VASCADE® portfolio of vascular closure systems featuring an innovative collapsible disc technology and a proprietary resorbable collagen patch designed to promote rapid hemostasis.